Skip to main content
Erschienen in: Clinical Orthopaedics and Related Research® 5/2013

01.05.2013 | Clinical Research

A Long Femoral Stem Is Not Always Required in Hip Arthroplasty for Patients With Proximal Femur Metastases

verfasst von: Zhiqing Xing, MD, PhD, Bryan S. Moon, MD, Robert L. Satcher, MD, PhD, Patrick P. Lin, MD, Valerae O. Lewis, MD

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

During hip arthroplasties for treating proximal femur metastases, a long femoral stem frequently is used, presumably protecting the entire femur against progression of the existing lesions or development of new lesions. However, it is unclear whether a long stem is really required.

Questions/purposes

We therefore determined in patients with proximal femur metastases (1) the reoperation rate related to different stem lengths after hip arthroplasty, (2) the risk of tumor progression in the same femur (the progression of preexisting lesions and the development of new distal femur lesions), and (3) complications.

Methods

We retrospectively reviewed 203 patients (206 femurs) with proximal femur metastases treated with hip arthroplasty. These femurs were divided into three groups based on femoral stem length: short stem (SS), 12 to 14 cm; medium stem (MS), 20 to 24 cm; and long stem (LS), 25 to 35 cm. We reviewed reoperations, disease progression in the same femur, and complications. Minimum followup was 2 days (median, 487 days; range, 2–4853 days), with most patients followed to their death.

Results

Only three femurs were revised owing to tumor progression, with no difference among the SS, MS, and LS groups. Two SS prostheses were revised for nononcologic reasons. Tumor progression in the same femur was uncommon during the patient’s survival, with 11 femurs showing progression of the proximal lesion and five femurs showing new distal lesions. The complication rate was higher in the LS group (28%) than the combined rate in the MS and SS groups (16%), especially acute cardiopulmonary complications (18% versus 7.5%).

Conclusions

Reoperation after hip arthroplasty for proximal femur metastases is uncommon and not correlated with femoral stem length. Considering the high complication rate associated with a LS hip prosthesis, we do not believe its routine use is justified.

Level of Evidence

Level III, therapeutic study. See Instructions for Authors for a complete description of levels of evidence.
Literatur
1.
Zurück zum Zitat Bielecki T, Gazdzik TS, Jurkiewicz A. Possibilities of surgical treatment of bone metastases to the proximal epiphysis of the femur: a review of the literature and own experience. Ortop Traumatol Rehabil. 2003;5:305–312.PubMed Bielecki T, Gazdzik TS, Jurkiewicz A. Possibilities of surgical treatment of bone metastases to the proximal epiphysis of the femur: a review of the literature and own experience. Ortop Traumatol Rehabil. 2003;5:305–312.PubMed
2.
Zurück zum Zitat Biermann JS, Holt GE, Lewis VO, Schwartz HS, Yaszemski MJ. Metastatic bone disease: diagnosis, evaluation, and treatment. J Bone Joint Surg Am. 2009;91:1518–1530.PubMed Biermann JS, Holt GE, Lewis VO, Schwartz HS, Yaszemski MJ. Metastatic bone disease: diagnosis, evaluation, and treatment. J Bone Joint Surg Am. 2009;91:1518–1530.PubMed
3.
Zurück zum Zitat Body JJ. New developments for treatment and prevention of bone metastases. Curr Opin Oncol. 2011;23:338–342.PubMedCrossRef Body JJ. New developments for treatment and prevention of bone metastases. Curr Opin Oncol. 2011;23:338–342.PubMedCrossRef
4.
Zurück zum Zitat Chrobok A, Spindel J, Mrozek T, Miszczyk L, Koczy B, Tomasik P, Matysiakiewicz J. Partial long-stem resection Austin-Moore hip endoprosthesis in the treatment of metastases to the proximal femur. Ortop Traumatol Rehabil. 2005;7:600–603.PubMed Chrobok A, Spindel J, Mrozek T, Miszczyk L, Koczy B, Tomasik P, Matysiakiewicz J. Partial long-stem resection Austin-Moore hip endoprosthesis in the treatment of metastases to the proximal femur. Ortop Traumatol Rehabil. 2005;7:600–603.PubMed
5.
Zurück zum Zitat Coluzzi F, Di Bussolo E, Mandatori I, Mattia C. Bone metastatic disease: taking aim at new therapeutic targets. Curr Med Chem. 2011;18:3093–3115.PubMedCrossRef Coluzzi F, Di Bussolo E, Mandatori I, Mattia C. Bone metastatic disease: taking aim at new therapeutic targets. Curr Med Chem. 2011;18:3093–3115.PubMedCrossRef
6.
Zurück zum Zitat Doung YC, Kenan S, Rapp T. Metastatic lesions of the proximal femur. Bull NYU Hosp Jt Dis. 2011;69:81–86.PubMed Doung YC, Kenan S, Rapp T. Metastatic lesions of the proximal femur. Bull NYU Hosp Jt Dis. 2011;69:81–86.PubMed
7.
Zurück zum Zitat Harrington KD. New trends in the management of lower extremity metastases. Clin Orthop Relat Res. 1982;169:53–61.PubMed Harrington KD. New trends in the management of lower extremity metastases. Clin Orthop Relat Res. 1982;169:53–61.PubMed
8.
Zurück zum Zitat Herrenbruck T, Erickson EW, Damron TA, Heiner J. Adverse clinical events during cemented long-stem femoral arthroplasty. Clin Orthop Relat Res. 2002;395:154–163.PubMedCrossRef Herrenbruck T, Erickson EW, Damron TA, Heiner J. Adverse clinical events during cemented long-stem femoral arthroplasty. Clin Orthop Relat Res. 2002;395:154–163.PubMedCrossRef
9.
Zurück zum Zitat Jacofsky DJ, Haidukewych GJ. Management of pathologic fractures of the proximal femur: state of the art. J Orthop Trauma. 2004;18:459–469.PubMedCrossRef Jacofsky DJ, Haidukewych GJ. Management of pathologic fractures of the proximal femur: state of the art. J Orthop Trauma. 2004;18:459–469.PubMedCrossRef
10.
Zurück zum Zitat Nakashima H, Katagiri H, Takahashi M, Sugiura H. Survival and ambulatory function after endoprosthetic replacement for metastatic bone tumor of the proximal femur. Nagoya J Med Sci. 2010;72:13–21.PubMedCrossRef Nakashima H, Katagiri H, Takahashi M, Sugiura H. Survival and ambulatory function after endoprosthetic replacement for metastatic bone tumor of the proximal femur. Nagoya J Med Sci. 2010;72:13–21.PubMedCrossRef
11.
Zurück zum Zitat Patterson BM, Healey JH, Cornell CN, Sharrock NE. Cardiac arrest during hip arthroplasty with a cemented long-stem component: a report of seven cases. J Bone Joint Surg Am. 1991;73:271–277.PubMed Patterson BM, Healey JH, Cornell CN, Sharrock NE. Cardiac arrest during hip arthroplasty with a cemented long-stem component: a report of seven cases. J Bone Joint Surg Am. 1991;73:271–277.PubMed
12.
Zurück zum Zitat Randall RL, Aoki SK, Olson PR, Bott SI. Complications of cemented long-stem hip arthroplasties in metastatic bone disease. Clin Orthop Relat Res. 2006;443:287–295.PubMedCrossRef Randall RL, Aoki SK, Olson PR, Bott SI. Complications of cemented long-stem hip arthroplasties in metastatic bone disease. Clin Orthop Relat Res. 2006;443:287–295.PubMedCrossRef
13.
Zurück zum Zitat Schneiderbauer MM, von Knoch M, Schleck CD, Harmsen WS, Sim FH, Scully SP. Patient survival after hip arthroplasty for metastatic disease of the hip. J Bone Joint Surg Am. 2004;86:1684–1689.PubMed Schneiderbauer MM, von Knoch M, Schleck CD, Harmsen WS, Sim FH, Scully SP. Patient survival after hip arthroplasty for metastatic disease of the hip. J Bone Joint Surg Am. 2004;86:1684–1689.PubMed
14.
Zurück zum Zitat Selek H, Basarir K, Yildiz Y, Saglik Y. Cemented endoprosthetic replacement for metastatic bone disease in the proximal femur. J Arthroplasty. 2008;23:112–117.PubMedCrossRef Selek H, Basarir K, Yildiz Y, Saglik Y. Cemented endoprosthetic replacement for metastatic bone disease in the proximal femur. J Arthroplasty. 2008;23:112–117.PubMedCrossRef
15.
Zurück zum Zitat Sokolovski VA, Voloshin VP, Aliev MD, Zubikov VS, Saravanan SA, Martynenko DV, Nisichenko DV, Strelnikov KN. Total hip replacement for proximal femoral tumours: our midterm results. Int Orthop. 2006;30:399–402.PubMedCrossRef Sokolovski VA, Voloshin VP, Aliev MD, Zubikov VS, Saravanan SA, Martynenko DV, Nisichenko DV, Strelnikov KN. Total hip replacement for proximal femoral tumours: our midterm results. Int Orthop. 2006;30:399–402.PubMedCrossRef
16.
Zurück zum Zitat Tonini G, Vincenzi B, Santini D. Bisphosphonate anticancer activity. Expert Opin Pharmacother. 2011;12:681–683.PubMedCrossRef Tonini G, Vincenzi B, Santini D. Bisphosphonate anticancer activity. Expert Opin Pharmacother. 2011;12:681–683.PubMedCrossRef
17.
Zurück zum Zitat Townsend PW, Smalley SR, Cozad SC, Rosenthal HG, Hassanein RE. Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys. 1995;31:43–49.PubMedCrossRef Townsend PW, Smalley SR, Cozad SC, Rosenthal HG, Hassanein RE. Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys. 1995;31:43–49.PubMedCrossRef
18.
Zurück zum Zitat Utzschneider S, Wicherek E, Weber P, Schmidt G, Jansson V, Durr HR. Surgical treatment of bone metastases in patients with lung cancer. Int Orthop. 2010;35:731–736.PubMedCrossRef Utzschneider S, Wicherek E, Weber P, Schmidt G, Jansson V, Durr HR. Surgical treatment of bone metastases in patients with lung cancer. Int Orthop. 2010;35:731–736.PubMedCrossRef
19.
Zurück zum Zitat Walker RH. Pelvic reconstruction/total hip arthroplasty for metastatic acetabular insufficiency. Clin Orthop Relat Res. 1993;294:170–175.PubMed Walker RH. Pelvic reconstruction/total hip arthroplasty for metastatic acetabular insufficiency. Clin Orthop Relat Res. 1993;294:170–175.PubMed
20.
Zurück zum Zitat Wedin R. Surgical treatment for pathologic fracture. Acta Orthop Scand Suppl. 2001;72:1–29. Wedin R. Surgical treatment for pathologic fracture. Acta Orthop Scand Suppl. 2001;72:1–29.
Metadaten
Titel
A Long Femoral Stem Is Not Always Required in Hip Arthroplasty for Patients With Proximal Femur Metastases
verfasst von
Zhiqing Xing, MD, PhD
Bryan S. Moon, MD
Robert L. Satcher, MD, PhD
Patrick P. Lin, MD
Valerae O. Lewis, MD
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Clinical Orthopaedics and Related Research® / Ausgabe 5/2013
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-013-2790-4

Weitere Artikel der Ausgabe 5/2013

Clinical Orthopaedics and Related Research® 5/2013 Zur Ausgabe

Symposium: Special Considerations for TKA in Asian Patients

Painful Patellar Clunk or Crepitation of Contemporary Knee Prostheses

Symposium: Special Considerations for TKA in Asian Patients

Comparative Demographics, ROM, and Function After TKA in Chinese, Malays, and Indians

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Traumatologische Notfälle Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.